Match!

User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

Published on Jun 1, 2017in International Journal of Mental Health and Addiction1.42
· DOI :10.1007/s11469-016-9650-x
Marie Claire Van Hout16
Estimated H-index: 16
(WIT: Waterford Institute of Technology),
Evelyn Hearne5
Estimated H-index: 5
(WIT: Waterford Institute of Technology)
Abstract
Emergence of synthetic cannabinoids (SCBs) in herbal smoking mixtures is a public health concern. New SCB’s such as 5f-AKB48 and 5F-PB-22 have been detected in French seizures and in sudden death post mortems in the US. The aim was to describe development of dependence on herbal smoking mixtures containing the SCB’s, 5f-AKB48 and 5F-PB-22 and subsequent withdrawal syndromes. Dependent users of herbal smoking mixtures known to contain the SCB’s 5f-AKB48 and 5F-PB-22 with an average Severity of Dependence Score (SDS) of 13 were interviewed using a structured guide (three males/three females). Narratives were analysed using the Empirical Phenomenological Psychological (EPP) five step method. Six themes with 68 categories emerged from the analysis. Themes are illustrated as 1) Networks and Product Availability; 2) Drivers and Motives for Use; 3) Effect and Pathways toward Dependence; 4) Poly Substance Use and Comparisons to Natural Cannabis; 5) Dependence and Withdrawal and 6) Self-detoxification Attempts. Two higher levels of abstraction above these theme-levels emerged from the data, with sole use of herbal smoking mixtures containing 5f-AKB48 and 5F-PB-22 centering on the interplay between intense cravings, compulsive all-consuming seeking, use and re-dose behaviours, and fear of the psychiatric and self-harms caused when in withdrawal. This is the first study describing dependence and withdrawal experiences in users dependent on 5f-AKB48 and 5F-PB-22. Given the potential for adverse psychiatric and physical consequences of dependent use, further development of specific clinical responses and clinical research around toxicity and withdrawal severity are warranted.
  • References (79)
  • Citations (16)
References79
Newest
#1Celeste M. Caviness (Butler Hospital)H-Index: 9
#2Golfo K. Tzilos (Brown University)H-Index: 11
Last.Michael D. Stein (Brown University)H-Index: 52
view all 4 authors...
#1Michael H. Baumann (NIDA: National Institute on Drug Abuse)H-Index: 48
#2Ernesto Solis (VCU: Virginia Commonwealth University)H-Index: 8
Last.Jenny L. Wiley (RTP: Research Triangle Park)H-Index: 45
view all 6 authors...
#1Erik W. Gunderson (UVA: University of Virginia)H-Index: 19
#2Heather M. Haughey (UVA: University of Virginia)H-Index: 3
Last.Carl L. Hart (Columbia University)H-Index: 34
view all 5 authors...
Cited By16
Newest
#1Jasmin Grigg (Monash University)H-Index: 4
#2Victoria Manning (Monash University)H-Index: 22
Last.Dan I. Lubman (Monash University)H-Index: 49
view all 4 authors...
#1Hina Akram (UCL: University College London)H-Index: 1
#2Claire Mokrysz (UCL: University College London)H-Index: 9
Last.H. Valerie Curran (UCL: University College London)H-Index: 41
view all 3 authors...
#1Samuel D. Banister (Stanford University)H-Index: 17
#2Alexander Olson (UCSF: University of California, San Francisco)H-Index: 3
Last.Iain S. McGregor (USYD: University of Sydney)H-Index: 66
view all 12 authors...
#1Amneh Al-Husseini (UJ: University of Jordan)H-Index: 1
#2Mayyada Wazaify (UJ: University of Jordan)H-Index: 14
Last.Marie Claire Van Hout (University of Liverpool)H-Index: 16
view all 3 authors...
#1Szilvia Kassai (ELTE: Eötvös Loránd University)H-Index: 2
#2Judit Nóra Pintér (University of Szeged)H-Index: 1
Last.V. Anna Gyarmathy (Semmelweis University)H-Index: 17
view all 7 authors...
View next paperThe synthetic cannabinoid withdrawal syndrome.